July 2019 |
|
Grassley: Goldilocks Moment to Reduce Rx Prices
|
|
Congress Passes Grassley Legislation to Help Children with Special Health Care Needs
|
|
Grassley On the Benefits of USMCA: Vilsack Testifies
|
|
ICYMI: Libertarian Cato Institute Supports Finance Committee’s Medicare Part D Reforms
|
|
Grassley Statement on Newly-Released GAO Report on Medicaid Supplemental Payments
|
|
Grassley on Spread Pricing
|
|
The Benefits of USMCA
|
|
Grassley’s Rx Bill Passes: “Unprecedented,” “Historic,” “Blockbuster,” “Tipping Point,” “Sweeping,” “Ambitious,” “Major”
|
|
Grassley Statement on Committee Passage of Prescription Drug Pricing Reduction Act
|
|
Grassley On The Prescription Drug Pricing Reduction Act of 2019
|
|
Stakeholder, Expert Endorsements Grow for Finance Committee Prescription Drug Legislation
|
|
Grassley On Tax Extenders Benefits
|
|
Grassley On Treasury, Tax Court Nominations
|
|
Grassley On USMCA Manufacturing
|
|
Support Rolls in for Finance Committee Prescription Drug Package
|